Palonosetron versus older 5-HT(3) receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

BACKGROUND: No clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, particularly delayed nausea. OBJECTIVE: To compare the efficacy and safety of palonosetron with older 5-HT(3) receptor antagonists (RAs) in preventing chemotherapy-induced nause...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Community Support Oncol
Prif Awduron: Morrow, Gary R, Schwartzberg, Lee, Barbour, Sally Y, Ballinari, Gianluca, Thorn, Michael D, Cox, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734136/
https://ncbi.nlm.nih.gov/pubmed/25830233
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg